You searched for "DMO"
Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...HS-UK Slit Lamp Basic Skills Course
13 March 2025
The Slit Lamp Basic Skills Course offers a full day of training and includes over two hours of hands-on workshops with product experts. Designed by clinicians, for clinicians, the course is delivered by guest speaker, Dr Sunil Mamtora. Beginning with...
HS-UK Slit Lamp Basic Skills Course June
17 June 2025
The Slit Lamp Basic Skills Course offers a full day of training and includes over two hours of hands-on workshops with product experts. Designed by clinicians, for clinicians, the course is delivered by guest speaker, Dr Sunil Mamtora. Beginning with...
HS-UK Slit Lamp Basic Skills Course Oct
2 October 2025
The Slit Lamp Basic Skills Course offers a full day of training and includes over two hours of hands-on workshops with product experts. Designed by clinicians, for clinicians, the course is delivered by guest speaker, Dr Sunil Mamtora. Beginning with...
RaScaL Study
1 June 2015
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Diabetic macular edema, Fluorescein angiography, Anti-VEGF, Ranibizumab, Laser photocoagulation, Combination therapy, Optical coherence tomography
The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...
Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage?
1 October 2017
| Efrosini Papagiannuli
|
Retina / Uvea / Vitreous
This retrospective, interventional case series, aimed to assess the effectiveness of intravitreal bevacizumab (IVB) in vitreous haemorrhage secondary to proliferative diabetic retinopathy. The primary outcome was the rate of vitrectomy (PPV) after IVB, with secondary outcomes the number of IVB...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
Ophthalmology
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
NICE drugs: an update on what’s good to go
1 June 2014
| Rod McNeil
|
AMD, Emergency Ophthalmology, Genetics, Ophthalmology, Optometry, EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...
Lucentis for pseudophakic CMO
1 October 2015
| Saruban Pasu
|
Retina / Uvea / Vitreous
|
Cataract, Irvine-Gass syndrome, cystoid macular edema, phacoemulsification, ranibizumab
Pseudophakic cystoid macular oedema (CMO) develops angiographically in up to 20-30% after uneventful phacoemulsification. This study aimed to evaluate the potential efficacy and safety of intravitreal ranibizumab in patients with pseudophakic CMO after cataract surgery. Seven eyes were included in...
Patients’ perspective over quality of care and cataract surgery
1 August 2017
| Mrinal Rana
|
Neuro-Ophthalmology
|
Cataract surgery, exploratory factor analysis (EFA), patient satisfaction, quality of care, treatment process
This study analyses the factors of perceived quality of care among patients undergoing cataract surgery. A questionnaire was designed to assess the patients’ views about the quality of care using QUOTE (Quality of Care through the Patient’s Eyes), which assessed...
Risk calculation variability over time in OHT
1 June 2014
| Lorraine North
|
Glaucoma
In this study the authors aimed to assess the variability of the well documented risk model from the Ocular Hypertension Treatment Study (OHTS) that identified higher intraocular pressure (IOP), older age, lower central corneal thickness (CCT), greater vertical cup-to-disc ratio...
All eyes on Twiggy as she fronts new campaign warning us: don’t lose focus of your eye health
13 October 2022
Dame Twiggy Lawson fronts a new public awareness campaign focused on eye health, as cases of macular disease increase with our ageing population.